Literature DB >> 10959455

[Electrocardiography and echocardiography aspects of hypertrophic myocardiopathy in pediatrics].

B Maldonado Tapia1, J Calderón Colmenero, A de Micheli, M Rijlaarsdam, J M Casanova Garcés, F Attie, A Buendia.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease, characterized by asymmetric hypertrophy of the left and/or right ventricle with disarray of myocardial fibers. In order to know its clinical and electrocardiographic manifestation in the pediatric age group, we made a retrospective study of 24 cases from 1986 to 1995. There were: 15 girls and 9 boys, with a mean age of 6 years (age range: 1 month to 17 years). Clinical manifestations were dyspnea (71%), syncope (42%) and palpitations (42%). Physical examination disclosed an aortic systolic murmur in all patients, a mitral regurgitation in 42% and physical signs of congestive heart failure in 54% of patients. Chest X rays showed cardiac enlargement in 71% and pulmonary capillary hypertension in 42%. The most frequent ECG abnormalities were: a prolonged time in the intrinsecoid deflection onset on leads corresponding to the affected region, more or less deep and clean Q waves on leads aVF, aVL, V5 and V6, as well as supraventricular and ventricular rhythm disturbances in 11 patients (46%) with and without congestive heart failure. Bidimensional echocardiography confirmed antero-septal hypertrophy in all patients. The mortality rate was 17%. HCM is rare disease in the pediatric age group. Mortality increases when congestive heart failure and arrhythmias are present. Treatment must be individualized in all cases.

Entities:  

Mesh:

Year:  2000        PMID: 10959455

Source DB:  PubMed          Journal:  Arch Inst Cardiol Mex


  2 in total

Review 1.  R-Peak Time: An Electrocardiographic Parameter with Multiple Clinical Applications.

Authors:  Andrés Ricardo Pérez-Riera; Luiz Carlos de Abreu; Raimundo Barbosa-Barros; Kjell C Nikus; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-11-02       Impact factor: 1.468

2.  The predictive value of R-wave peak time on no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.

Authors:  Ahmed Bendary; Mohamed El-Husseiny; Tarek Aboul Azm; Ahmed Abdoul Moneim
Journal:  Egypt Heart J       Date:  2018-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.